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Abstract  
Background: Diabetes mellitus (DM) is a major metabolic disorder characterized by chronic 
hyperglycemia; with disturbances of carbohydrate, protein and fat metabolism resulting from 
defects in insulin secretion, insulin action or both. Despite the introduction of hypoglycemic 
agents, diabetes and related complications continue to be a major health problem in the 21
st
 
century. In addition, many oral hypoglycemic agents have got major side effects and cannot be 
used during pregnancy. Therefore, searching new antidiabetic agents of less toxic plant origin are 
continued to be an area of active research as WHO also recommends. Therefore the main 
objective of this study was to investigate the oral antidiabetic activity of crude extract of root of 
Asparagus africanus Lam in Rodent models.  
 
Materials and method: In all models, rodents were divided in to five groups each comprising of 
six animals. In hypoglycemic model healthy fasted mice and for antidiabetic studies Streptozocin 
150 mg/kg induced diabetic mice, whereas for oral glucose tolerance test (OTT) rats were used. 
For group I distilled water was give as negative control, group II received 5mg/kg glibenclamide 
standard (GL5); groups III-V the extract of A. africanus 100 (AA100), 200 (AA200) and 400 
(AA400) mg/kg/day, were given respectively. Blood samples were collected at different time 
points to determine blood glucose levels (BGL). Data were analyzed using one way ANOVA 
followed by Dunnet’s post hoc test and p<0.05 was considered as statistically significant. 
 
Results: In normal fasted mice, extract 200 mg/kg/day induced hypoglycemia starting from the 
2
nd
 h (p<0.05) but AA100 mg/kg/day and AA400 mg/kg/day failed to produce hypoglycemia at 
all time points. In Streptozocin induced diabetic mice AA200 mg/kg/day and AA400 mg/kg/day 
reduced BGL significantly since the 2
nd
 h but at the 4
th
 h lowered BGL very significantly (p< 
0.001 in both cases). However, AA100 mg/kg/day revealed effect only at the 4
th
 h (p<0.05) in 
diabetic mice. In OGTT, AA200 and GL5 (p<0.001) achieved effect since 60 min indicating the 
oral glucose load improving activity of the extract. It is worth nothing finding that AA200mg is 
competing with the standard in all models. Acute oral toxicity test revealed the extract was non 
toxic up to 5000 mg/kg. Phytochemical screening demonstrated presence of bioactive molecules 
flavonoids, alkaloids, phenolic and others which ameliorates diabetes and its complications.  
 
Conclusion: The results of this study indicate A. africanus has potential antidiabetic actions, 
particularly at the dose of 200 mg/kg in experimental rodents supporting the traditional claim.  
Keywords: Asparagus africanus, Antidiabetic activity, Diabetes mellitus, Streptozocin. 
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1. INTRODUCTION 
1.1 Background 
Diabetes mellitus (DM) is a group of major metabolic disorder of multiple etiologies 
characterized by chronic hyperglycemia; with disturbances of carbohydrate, protein, and fat 
metabolism, resulting from defects in insulin secretion, insulin action, or both (1). A number of 
studies also showed that impaired metabolism is usually associated with oxidative stress, 
mediated mainly by hyperglycemia induced generation of excessive free radicals through lipid 
peroxidation, alteration of the activity of several proteins, aggravated by a drastic drop in 
antioxidant immune mechanisms. This imbalance generally lead to oxidative stress which is the 
main factor associated with the severity and death in diabetes patients (2, 3).  
The acute complication of DM is ketoacidosis, dehydration electrolyte imbalance and others. Its 
long-term complications are retinopathy with potential loss of vision; nephropathy resulting in 
renal failure; peripheral neuropathy with risk of foot ulcers, amputations and patients with 
diabetes have an increased incidence of atherosclerotic cardiovascular, peripheral arterial and 
cerebrovascular disease. The risk of micro vascular and neuropathic complications are related to 
both duration and the severity of hyperglycemia (1, 4)  
According to the latest International Diabetes Federation (IDF) estimation in 2013, the numbers 
of adults living with DM were about 382 million, representing 8.3% of the global adult 
population, which was projected to rise to 592 million people or 10.1% of adults by 2035 (4, 5)  
Currently there is a steady increase in the number of younger individuals with type II diabetes;  
mainly due to an increase in prevalence of obesity, risk factor for type II diabetes children  (6).  
Globally DM is considered as the fourth or fifth leading cause of death in most industrialized 
countries accounting for about 5.1 million deaths in 2013. Every six seconds a person dies from 
diabetes. This shows diabetes is undoubtedly one of the most challenging health problems of the 
21
st
 century. As the prevalence of type II diabetes grows in low and middle income countries, so 
too does the impact of these cost in both human and economic terms (4). In Africa, currently DM 
is rapidly spreading, because of rapid uncontrolled urbanization and westernization of life-style 
and dietary habits with varying prevalence across continent (6).  
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According to the extrapolated data, the prevalence of DM in Ethiopia was 4.9% in 2013 (5). A 
study done in 2014  showed the prevalence of diabetes mellitus among adults aged 35 years and 
above was 5.1% and 2.1% among people who lived in urban and rural respectively (7).  
Globally health expenditure spending to treat diabetes and manage its complications in 2013 was 
USD 548 billion and it will be speculated to exceed USD 627 billion by 2035 (4). 
 
Although to this extent DM is the major public health problem about 80% of the world 
population, especially resource limited countries benefited from the herbal medicine and greater 
than 50% of all drugs, in clinical use are herbal products or their derivatives  (8). Therefore 
searching of novel antidiabetic plant origin is one of the active research areas of researchers.  
1.1.1 Types of Diabetes mellitus 
DM is classified on the basis of the pathogenic process that leads to hyperglycemia, in to two 
broad categories as type I and type II (9-11). Type I DM majorly results from autoimmune beta 
cell destruction of the pancreas, which leads to complete or near-total insulin deficiency. Some 
develop insulin deficiency by unknown mechanism. It is most commonly develops before the 
age of 30 years but can develop at any age, since an autoimmune beta cell destructive process 
can occurs at any stage of life (6).  Type II DM is characterized by impaired insulin secretion, 
insulin resistance, excessive hepatic glucose production, and abnormal fat metabolism (1). 
Obesity, particularly visceral or central is very common in type II DM. Type II DM has a strong 
genetic component. The concordance of type II DM in identical twins is between 70 and 90%. 
Individuals with a parent with type II DM have an increased risk of diabetes; if both parents have 
type II DM, the risk approaches 40. There are Gestational Diabetes Mellitus (GDM) and others 
specific types of DM (1, 9) 
1.1.2 Risk factors of diabetes mellitus 
The modifiable risk factors which are associated with type of diabetes include increase in 
sedentary lifestyle, consumption of energy rich diets, low in fiber diet; obesity and decreased 
physical activity while the non modifiable risk factors of  diabetes include age, ethnicity, Genetic 
predisposition are also associated with the development of diabetes mellitus (9). 
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1.1.3 Pathophysiology of Diabetes mellitus 
Type I DM is the result of interactions of genetic, environmental, and immunologic factors that 
ultimately lead to the destruction of the pancreatic beta cells and insulin deficiency. Most results 
from beta cell loss is a T-cell mediated autoimmune destruction, some have evidence of islet 
directed autoimmunity the majority of type I diabetes is of the immune mediated nature (12). 
Type II DM is a complex metabolic disorder with multiple Pathophysiologic abnormalities. 
Insulin resistance and beta-cell failure represent the core defects. Patients impaired glucose 
tolerance (IGT) is near maximally insulin resistant and have lost 80% of their beta cell function. 
Accelerated lipolysis, gastrointestinal tract incretin deficiency or resistance, hyperglucagonemia, 
and other factors play major roles in development of glucose intolerance in type II DM (13).  
1.1.4 Diagnosis of diabetes mellitus 
Symptoms of marked hyperglycemia include polyuria, polydipsia, weight loss, sometimes with 
polyphagia, and blurred vision. But these symptoms have to be supported by DM diagnostic 
criteria. For decades, the diagnosis of diabetes has been based on glucose criteria, either the 
fasting plasma glucose (FPG) or the 75g  oral glucose tolerance test (OGTT)(1),which is fasting 
plasma glucose level at or above 126 mg/dL, plasma glucose at or above 200 mg/dL two hours 
after a 75 g oral glucose load in a glucose tolerance test and  random plasma glucose at or above 
200 mg/dL. Epidemiological studies confirmed the long-standing diagnostic 2-h plasma glucose 
(PG) value of ≥ 200 mg/dL. However, the older FPG diagnostic cut point of 140 mg/dL was 
noted to identify far in fewer individuals with diabetes than the 2-h PG cut point, so ≥ 126 mg/dL 
is now used. Glycated hemoglobin (A1C) 5.7–6.4% is also used commonly to diagnose diabetes 
in individuals with risk factors (1, 9, 14, 15). 
1.1.5 Management and Prevention of Diabetes mellitus 
DM is a chronic disease, therefore  non pharmacological (life style modification & diet control) 
and pharmacological approaches (insulin and oral hypoglycemic agents) are required to improve 
the prognosis of patients, their quality of life and to decrease morbidity and mortality from 
micro- and macro-vascular complications (16). For type I DM the first and remain the primary 
treatment option is administration of insulin (15, 16). Management of Type II DM starts from the 
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non-pharmacologic means and then to the oral hypoglycemic agents such as sulphonylureas, 
biguanides, thiazolidinediones, meglitinides, in cretins, amylinanalogues, alpha-glucosidase 
inhibitor etc  or Combination of these agents with one another or insulin are used according to 
the stage of the DM (9, 13, 14). 
Primary prevention aimed at long-term weight control because obesity is a major risk factor 
strongly associated with insulin resistance and lifestyle modifications are likely to be most 
successful in delaying or preventing type II DM (15).  
Nowadays medicinal plants also play a pivotal role in prevention, managing DM and related 
complications due to their secondary metabolites. Herbs are the main source of medicinal agents 
and a large number of medicinal herbs are found to be efficacious, cheap and safe in preventing 
diabetes and diabetic complications (10, 14, 17-19).  
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1.2 Statement of the problem 
Since time immemorial, traditional medicinal plants have been used to treat patients with 
diabetes mellitus especially type II (8, 18). In many countries of the world, ethno 
pharmacological studies showed a number of plants used for the management of diabetes and 
some of them have been experimentally evaluated and the active principles were isolated (13). 
Ethnobotanical information suggests about 800-1200 medicinal plants may possess antidiabetic 
potential in the world (19, 20).  But little is known on the specific modes of action of these plants 
for treating diabetes although insulin mimetic or secretagogues activity has been proposed for 
some (21). 
 Based on the WHO recommendations hypoglycemic agents of plant origin used in traditional 
medicine are important source for DM management. Plant agents and herbal formulation are 
usually less toxic and free from side effects than synthetic one (20, 21). 
 In spite of the introduction of hypoglycemic agents, DM and its complications continue to be a 
major health problem worldwide in the 21
st
 century (5). In addition with increasing incidence of 
diabetes mellitus in resource limited countries throughout the world and due to adverse effects of 
synthetic medicine, as a result of these serious side effects they are not suitable for use during 
pregnancy (22).  
Investigating the safety and efficacy of these plants in animal model could give valuable 
information in this regard. The public could be benefited from the use of plants if the safety and 
efficacy is proved at large, since we are the most users of traditional medicine in the world which 
is about 90% (23). Thus, there is a clear need for development of indigenous, inexpensive 
botanical sources for antidiabetic crude or purified drugs. 
 
 
 
 
6 
 
1.3 The Genus Asparagus 
 Modern taxonomists have placed the genus Asparagus in family Asparagaceae of order 
Asparagales rather than in Liliaceae. The family Asparagaceae contains two other genera, 
Myrsiphyllum and Protasparagus. The genus Asparagus includes about 370 species around the 
world. Many species of the genus Asparagus are medicinally very important and novel chemicals 
have been isolated from roots, stem and cladodes (24). 
1.3.1 Botanical Background Asparagus africanus Lam. 
A.africanus Lam: - belonging to the family Asparagaceae is medicinal shrub valued for its 
medicinal properties. It is widely distributed throughout Africa including Ethiopia, parts of 
Europe, Asia and Australia (25). A.africanus Lam, with a common name African asparagus is a 
perennial shrub or climber with stems up to 6 meters high growing between 700 and 3800m 
above sea level (25) [Figure 1]. 
 
 
Figure 1   Picture of Asparagus africanus Lam. and its root 
1.3.2 Traditional and Pharmacological uses of Asparagus africanus Lam 
 Traditionally A. africanus is used to treat various human ailments in Ethiopia and other African 
countries including Diabetes mellitus. Two anti protozoan compounds, muzanazagenin and 
lignan have been isolated from its roots of A.africanus Lam to treat different protozoan diseases. 
The extract of this plant exhibit effects in treating: bilharziasis, syphilis, gonorrhoea, 
lishmaniasis, malaria, inflammation, impotence which were confirmed scientifically (25-28), anti 
fertility, as birth canal dilator (29). 
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A study done in Nigeria on its analgesic and antinflammatory effects showed effective as that of 
Indometacin, in fact in dose dependant manner. Concerning its toxicity profile, the methanolic 
extract of the roots of A.africanus did not cause  mortality up to the dose of 5000 mg/kg orally 
and  thus considered to be none toxic (28). In Kenya, it has been used for centuries as a 
traditional drug (26). Many species of the genus Asparagus including A. officinalis L, A. 
ascendens and A. racemosus were researched in various parts of the world for their antidiabetic 
effects and scientifically validated with different proposed mechanisms of actions, with leading 
of insulin mimetic (2, 30). The use of A. africanus Lam, for management of DM is reported 
ethinobotany in Nigeria (31). A. africanus in Ethiopian folk medicine is also used traditionally 
for management of DM. On the other hand, since many of the genus Asparagus have shown 
potential antidiabetic actions, this is clue to investigate A.africanus to manage diabetes as 
supported by previous reports that plants with similar genus having similar effects (32).  
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1.4 Significance of the Study 
DM is one of the most challenging health problems in the 21
st
 century and the world’s largest 
emerging metabolic disorder of the endocrine system, afflicting the globe population at the 
alarming rate. Despite this managing the growing number of disease cases and developing new 
agents devoid of adverse effect are other challenges, because most of the drugs in current use are 
seriously limited by both their side effects and the cost of the treatment.  
Medicinal plants have been used traditionally for almost all kinds of diseases directly or 
indirectly since human history including fighting against DM, especially in resource limited 
countries like Ethiopia. However, most are without scientific proof for safety, efficacy and dose 
specification. A.africanus Lam is among these commonly used medicinal plants with no 
scientific validation for Diabetes mellitus. Therefore it needs scientific justification to be 
validated as safe and effective to combat DM.  
 It is then an urgent need to search for new antidiabetic drugs which ideally should be not only 
more efficacious and less toxic than the current ones, but also cheap and available especially in 
rural areas, thus discovering new agents to overcome these all challenges is straight forward 
hoping to come up with suitable drug for mankind. It is also important as scientific evidence for 
promoting our traditional medicine for the rest of the world. 
The results of pharmacological screening of claimed plant could have a contribution in the 
discovery of new medicinal plant with antidiabetic activity. This delivers baseline data for those 
researchers who are engaged to search medicinal plants with antidiabetic activity. Therefore the 
present study aims to investigate the antidiabetic activity of root extract of A. africanus in rodent 
models.  
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2. OBJECTIVES 
2.1 General Objective 
To investigate the oral antidiabetic activity of crude extract of root of Asparagus africanus Lam. 
(Asparagaceae) in Rodent models.  
2.2 Specific Objectives 
 To perform preliminary phytochemical screening of the crude root extract  
 To assess the acute oral toxicity of the 80% methanolic root extract of A. africanus 
 To assess hypoglycemic effect of root extract of A. africanus in normal fasted mice 
 To evaluate effect of root extract of A. africanus on Streptozocin induced diabetic mice 
 To assess the effect of root extract on oral glucose tolerance test in Glucose loaded rats 
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3. MATERIALS AND METHODS 
3.1 Materials  
3.1.1. Drugs, chemicals and equipments 
The following chemicals, reagents and drug were used for the experimental study: Streptozocin 
(Sigma Aldrich, China), Glucose standard strip/test kits and one touch glucometer (Accu-check 
Active
®
, Germany), Glibenclamide (Cadilla, India), tri-sodium citrate, citric acid and absolute 
methanol 99.8% (NATASO, India), Distilled water, glucose 40% solution (JE IL Pharma. Co., 
Daegu Korea), hydrochloric acid and benzene (Nice, Cochin-India), acetic acid, Mercuric 
chloride, iodine and potassium iodide (Supertek international Pvt, India), concentrated sulfuric 
acid, chloroform and glacial acetic acid (Avantor performance materials international Pvt,USA), 
copper sulphate, ammonia and ferric chloride (Avishker international Pvt, India),sodium 
carbonate (Guangzhou Jinhuada chemical reagent Co.,Ltd, China). All chemicals were analytical 
grade. 
In addition, the following equipments and supplies including : PH213 Microprocessor PH meter 
(HANNA Instruments, Italy), Whatman filter paper (Whatman LTD, England), mortar and 
pestle, diabetic syringe, syringe with needle of 3,5 and 10ml, beakers, separating funnels, 
Aluminum foil, measuring cylinders, Disposable glove, rat and mouse gavages and cages, tea 
filter, dry oven (250 +10% Volts AC 600 watts 50/60Hz, France), Electrical balance (Adam 
equipment CO. LTD), pasture pipette, stainless scissor, Erlenmeyer flask of different sizes were 
used.  
3.1.2. Plant materials 
Enough amount of the root of A. africanus Lam. was collected in December, 2013 in Amhara 
region, North Gondar, from University of Gondar Maraki Campus 730 km away from the capital 
city Addis Ababa. Identification and authentication of the plant specimen was done at Addis 
Ababa University the Department of Biology Herbarium and plant specimen was kept there with 
voucher number KA1783. 
11 
 
3.1.3. Experimental animals 
Healthy male Swiss albino mice (weighing 20–25 g and age of 8–10 weeks) and either sex 
Wistar rats (weighing 150-200 g and age of 2-3 months) were obtained from animal house of 
Pharmacology Department, School of Pharmacy, University of Gondar, both of them were in 
breed. Rodents were kept under standard condition (12 h light: 12 h dark cycle; 19-25°C) and 
pellet diet and water ad libtum. 
3.2   Methods 
3.2.1 Plant material preparation and extraction 
The collected fresh roots of A. africanus was cleaned with tap water to remove dirt, soil then 
with distilled water and air dried under shade at room temperature. The dried root was coarsely 
powdered by using portal and pestle. Two hundred fifty gram was macerated in 80% methanol 
by using Erlenmeyer flask for 72 hrs at room temperature. After 72 hrs, filtrate was separated 
from the marc using tea filter and further filtered by Whatman filter paper No.1. The marc was 
remacerated (33) twice using the same solvent. Following exhaustive extraction, the 
hydroalcoholic solvent was removed by evaporation in oven under 40°C to obtain the crude 
extract. The extract was kept in desiccators by appropriate small bottle container until used for 
experiment.  
3.2.2 Preliminary phytochemical screening 
Using standard procedures and reagents the crude extract was screened for the presence of 
secondary metabolites such as flavonoids, terpenoids, saponins, alkaloids, tannins, polyphenolic 
compounds, cardiac glycosides, reducing sugar, sterols and anthraquinones (33-35) (See annex). 
3.2.3 Acute oral toxicity test 
Acute oral toxicity for A.africanus Lam. extract was determined based on the limit test 
recommendations of OECD 425 Guideline. On day one, two female Swiss albino mice were 
fasted for 3-4 h but water was allowed and dosed 2000 mg/kg and 5000 mg/kg for each mouse 
the extract orally. The mice were then kept under strict observation during the first 4 h for 
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physical or behavioral changes such as feeding behavior, hair erection, lacrimation, salivation, 
mortality and other signs of toxicity manifestations for 24 h in different cadges (36).  
Following the results from each mouse, other six female mice were randomly selected and fasted 
for 3-4 h and a single dose of 2000 mg/kg for four and 5000 mg/kg for two mice were 
administered orally then observed in different cadges in the same manner as above. This 
observation was continued for further 14 days for any signs of overt toxicity. Based on the result 
acute toxicity LD50 was calculated for the proceeding procedure (36). 
3.3 Pharmacological screening 
3.3.1 Grouping and dosing of Rodents 
In all models, rodents were divided in to five groups each comprising of six. Hypoglycemic and 
anti diabetic studies were conducted on healthy male mice (37) in which diabetes was induced 
using Streptozocin 150 mg/kg with its about 66.7% efficacy of inducing type II diabetes (38, 39). 
Whereas, for oral glucose tolerance test  (OGTT), rats were used since they are preferable in 
such studies (40, 41). The doses were determined based on the acute toxicity study results of the 
lower limit test for the subsequent tests, thus the middle dose was one tenth of the limit dose that 
was 2000 mg/kg, which would be 200 mg/kg, the lower dose was calculated by taking half of 
middle dose, that means 100 mg/kg and higher dose was calculated as twice the middle dose that 
was 400 mg/ kg (3). 
Then rodents were grouped randomly in to five equal groups (n= 6/group). In all models, group I 
received distilled water and served as negative control; Group II received a standard, 
glibenclamide 5 mg/kg; Group III-V received 100, 200 and 400 mg/kg/day of A. africanus 
extract calculated from the results of acute toxicity test result respectively. Each dose of the 
extract and the control was administered orally for the test rodents (42). Measurement of BGL 
for each group at each interval of time was done in triplicate and the average value was taken to 
assure the data quality of the experimental study. 
3.3.2 Assessment of the effects of the extract on blood glucose level of normal fasted mice   
The mice were fasted overnight for 5-6 h, but water was allowed. Using aseptic precautions, 
blood was collected by cutting their tip of tails to determine pretreatment blood sugar levels 
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(BGL) (37, 43). Immediately afterwards, these mice were administered the vehicle, positive 
control and 100 mg/kg/day, 200 mg/kg/day and 400 mg/kg/day of the extract according to their 
respective randomly assigned groups. Blood samples were collected from overnight fasted 
rodents’ tails at 0, 1, 2, 3 and 4 h post treatments for the determination of BGL. 
3.3.3 Evaluation of the effect of the extract on Streptozocin induced diabetic mice 
Diabetes was induced in mice by a single intraperitonially injection 0.1 M Streptozocin (STZ). 
0.1 M citrate buffer was prepared by dissolving 2.1 g of citric acid and 2.94 g of sodium tri 
citrate in 100 ml of distilled water. The pH was adjusted to 4.5 by the proper addition in drop 
wise of 0.1 M NaOH/HCL of each using a calibrated pH meter (44). Immediately afterwards, the 
prepared 0.1 M 150 mg/Kg STZ was injected intraperitonially to the mice fasted 5-6 h hrs with 
aseptic precautions (37). Seventy two hours later, mice showing blood glucose level >200 mg/dL 
was selected. These mice were assigned randomly to five equal groups (n=6/group) and treated 
in the following manner; Group I distilled water, Group II received a standard, glibenclamide 5 
mg/kg and Group III-V received 100,200 and 400 mg/kg/day extract respectively. Then BGL 
was determined at 0, 1, 2, 3 and 4 h post treatment. 
3.3.4 Evaluation of the effect of the extracts on oral glucose tolerance test in rats 
Rats were fasted for 12-14 h over night (37) and assigned randomly into 5 equal groups (n= 
6/group). These rats were orally treated as follows: Group I was received distilled water, Group 
II received a standard drug, glibenclamide 5mg/kg, Group III-V were received Asparagus 
africanus extract in the same manner as above. One hour later, all these rats were orally loaded 
with 2 gm/kg glucose solution (45). Blood samples were collected from the tails of these rats 
immediately prior to commencement of treatment and at 30, 60 and 120 min after the glucose 
challenge and BGL was determined for each group (37).  
3.4 Statistical Analysis 
 
All the grouped data were statistically evaluated and the significance of various treatments was 
calculated using the one-way analysis of variance (ANOVA) followed by Dunnet’s post-hoc test  
to compare results between and within groups for difference between initial and final results. All 
the results were expressed as mean ± SEM of the six mice and rats in each group. The level of 
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significance was considered as significant P-value ≤ 0.05. All data processes were done by using 
SPSS data analysis soft ware of version 20.0. 
3.5 Ethical Clearance 
Ethical clearance was obtained from Pharmacology Department, College of Medicine and Health 
Sciences, University of Gondar, before the actual work begun. Rodents were handled according 
to OECD 425 and Guideline for reporting experiments involving animals: the arrive guideline 
(36, 46). 
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4. RESULTS 
4.1 Extraction 
The percentage yield of 80% methanolic extract of the dried root of A. africanus was found to be 
42.4% (w/w). The extract was brown, gummy semisolid at room temperature and solidified when 
stored in desiccators, since the extract was hygroscopic in its nature. It is very soluble in water 
forming a clear solution. 
4.2.Phytochemical test  
Preliminary phytochemical screening of the crude extract of A. africanus revealed the presence 
of bioactive secondary plant metabolites such as Flavonoids, alkaloids, tannins, saponins and 
others (Table 1).   
 Table 1: Phytochemical screening result of hydroalcoholic root extract of A. africanus  
 
+    Present                         - Absent 
4.3 Acute oral toxicity test  
Acute toxicity study of the methanolic root extract of A. africanus did not reveal any behavioral, 
neurological, autonomic or physical changes such as alertness, motor activity, restlessness, 
convulsions, coma, diarrhea and lacrimation. Besides, the extract did not cause mortality in the 
Test for secondary metabolite   Observed Results 
Flavonoids + 
Terpenoids + 
Saponins + 
Alkaloids + 
Tannins + 
Sterols + 
polyphenolic compounds + 
Cardiac glycosides - 
Anthraquinones - 
Reducing sugars + 
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mice at a dose of 2000 mg/kg and 5000 mg/kg during the observation time. Thus, the median 
lethal dose (LD50) of the root extract of the plant is said to be greater than 5000 mg/kg, 
indicating a very wide safety margin of the extract.  
4.4 The effects of root extract of A. asparagus on normal fasted mice 
As shown in Table 2, the effect root extract of A. africanus BGL of normal fasted mice between 
groups analysis revealed a significant difference among groups when compared with the base 
line.  The plant extract at 100 mg/kg/day failed to show significant hypoglycemic effect at all 
time points although percent reduction was (23.88%) at the 4
th
 h. However, significant 
hypoglycemia was recorded for A. africanus 200 mg/kg/day at the 3
rd
 (p<0.05) and 4
th
 h (p<0.01) 
with (34.16%) and (36.53%) reduction in BGL post treatment compared to the base line, 
respectively. Glibenclamide 5 mg (GL5) showed lowering BGL as early as the 1
st
 h and lasts till 
the end of the experiment with (p<0.001), when compared with the vehicle. GL5 percent 
reduction was found to be, 36.55%, 35.20%, 38.83% and 37.82% from 1
st
 -4
th
 h respectively. On 
the other hand, A. africanus 400 mg/kg/day did not cause any hypoglycemia at all time points 
which were similar to that of the negative control.  
Apparent statistical differences were not observed when the different doses of the extract were 
compared with each other. However, when the standard was compared with different doses of 
the extract there was statistical significance both with AA100 mg/kg/day and AA400 mg/kg/day 
from the 1
st
-3
rd
 h (p< 0.05). 
Within group analysis revealed that vehicle treated animals did not show any significant 
reduction in BGL across all time points compared to initial fasting or baseline level and the same 
is true for both AA200 mg/kg/day and AA400 mg/kg/day. But further within group comparisons 
for AA100 mg/kg/day extract indicated that there was a fall in BGL at the 3
rd
 and 4
th
 compared 
to 0 h (p< 0.05 and p< 0.01 h) respectively.  
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Table 2: Hypoglycemic effects of 80% methanolic root extract of Asparagus africanus on blood 
glucose levels in fasted normal mice 
                          Blood Glucose level in mg/dL 
Group  0 h  1 h  2 h  3 h  4 h  
Dis. H2O 96.00±2.44 89.33±2.82 88.28±3.95 86.34±3.90 84.95±4.91  
GL5mg 91.14±4.9 57.83±2.42a3b1d3e3 59.06±3.47a3b1d1e3 55.75±2.5a3b3d1e3 56.67±3.47a3b3d3e3  
AA 100mg 95.61±3.76 86.06±5.67 77.39±3.71e1 74.22±3.89e2 72.78±3.12
e2  
AA 200mg 104.80±11. 81.50±9.42 77.75±7.16 68.78±4.72a1 66.72±3.38a2  
AA 400mg 83.50±2.22 83.44±2.73 78.00±3.43 74.83±3.96 73.17±3.54  
Values are mean±SEM. n=6; 
a
compared to Dist H2O; 
b
compared to AA100 mg; 
c
compared to AA200 mg; 
d
compared to AA400 mg;
 e
compared to 0h;
 1
p<0.05; 
2
p<0.01; 
3
p<0.001. (Distilled H2O=negative control; GL 5 mg, 
glibenclamide 5 mg/kg; AA100, AA200 & AA400= A.africanus extracts mg /kg/day).
 
4.5 The effects root extract of A. asparagus on Streptozocin induced diabetic mice 
Forty five mice were injected 150 mg/kg Streptozotocin intraperitonially and 34 of them were 
found to be diabetic, with a success rate of 75.6%. Out of the thirty four mice, one died before 
the commencement of the experimental procedure, two with non recordable (high) BGL, as a 
result these mice were excluded but all the rest survived until the end of the experiment.  
The effect of root extract of A. africanus in Streptozotocin-induced diabetes was depicted in 
Table 3. Inter-group analysis indicated that no detectable changes were observed for the fasting 
base line BGL of diabetic control group. Interestingly, mice treated with different doses of 
extract and glibenclamide revealed fall in BGL compared to their initial values. Accordingly, 
AA100 mg/kg/day reduced BGL by 22.72% at the 3
rd
 h although it does not reached to statistical 
significant level but at 4
th
 h (p<0.01). However, extracts AA200 mg/kg/day (31.39, 41.09, 
56.02%) and AA400 mg/kg/day (23.58, 26.80, 40.85%) since the 2
nd
 h respectively reduced 
BGL with different significance level except at the
 
4
th
 h (p<0.001 in both cases) compared to 
vehicle took diabetic control group mice. In the same manner, GL5 (p<0.01, p<0.001 and 
p<0.001) did show a significant BGL reduction at the 2
nd
, 3
rd
 and 4
th
 h consecutively. Maximum 
BGL lowering effects were attained at the 4
th
 h, with percent reduction of 38.62%, 56.02%, 
40.85%, and 58.66% for AA100 mg/kg/day, AA200 mg/kg/day, AA400 mg/kg/day and GL5 
mg/kg/day respectively. No significant detectable changes were observed in BGL when, either 
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different doses of the extract compared to each other as well as when all extract doses compared 
with the positive control at all time points in cases of between group analysis of diabetic model.  
 Intra-group analysis demonstrated that vehicle treated mice had no effect on BGL at all-time 
points compared to the base line. Subsequent within group analysis indicated that AA100 
mg/kg/day do not significantly decreased BGL at all-time points. On the other hand it is worse 
nothing that AA200 mg and GL5 mg significantly controlled BGL in a similar pattern, with 
similar p-values becoming very significant at the 4
th
 h (p<0.001 in both cases). 
Table 3: Antidiabetic effects of 80% methanolic root extract of A. africanus on blood glucose 
level in Streptozotocin induced Diabetic mice 
Blood glucose level in mg/dL 
Group  0 h 1 h 2 hrs 3 hrs 4hrs 
Distilled H2O 347.61±41.82 347.84±37.70 341.33±15.44 337.22±11.69 332.17±11.13 
GL 5 mg 337.22±33.32 304.94±36.03 217.33±17.11
a1e1
 177.67±13.19
a3e1f1
 139.39±12.00
a3e2f2
 
AA100 mg 340.17±39.26 330.17±37.54 277.39±39.45 262.89±34.69 208.78±42.19
a2
 
AA 200 mg 339.78±36.23 317.89±30.62 233.11±10.60
a1e1
 200.17±14.92
a2e1f1
 149.44±13.33
a3e1f1
 
AA 400 mg 287.95±31.50 260.56±33.10 220.06±32.70
a2
 210.78±27.58
a1
 170.33±32.09
a3
 
Values are mean±SEM. n=6; 
a
compared to Dist H2O; 
b
compared to100 mg; 
c
compared to 200 mg; 
d
compared to 400 
mg;
 e
compared to 0h; 
f
compared to 1h;
 1
p<0.05; 
2
p<0.01; 
3
p<0.001. (Distilled H2O=negative control; GL 5 mg, 
glibenclamide 5 mg/kg; AA100, AA200 & AA400= A.africanus extracts mg /kg/day).
 
4.6 The effects of A. asparagus extract on oral glucose tolerance test in glucose loaded rats 
Effects of the extract of A. africanus OGTT were shown in Table 4. BGL of all groups prior to 
extract administration (0 min) showed no apparent difference compared to each other. However    
all groups, revealed rapid increase in BGL by 32.0 to 42.13% from initial level, 30 min following 
extract administration or after one hour oral glucose loading, confirming the induction of 
hyperglycemia. Hyperglycemia with glucose challenge was not significantly brought down with 
the distilled water handled rats at all time points. AA100 mg/kg/day produced a detectable BGL 
changes at 60 min and 120 min (p<0.01, p<0.001) with 32.28% and 36.95% utilized glucose 
consecutively. In the same way AA200 mg/kg/day caused a very significant reduction of BGL at 
60 min and 120 min (p< 0.001 in both cases) with percentage of 34.01%, 43.48% respectively.  
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A.africanus 400 mg/kg/day extract caused a fall in BGL to a significant level only at 60 min 
(p<0.01 with 34.36%) but at 120 min although percentage of BGL reduction was more than 
double compared to the vehicle which was 29.97%, found to be non significant statistically. GL5 
produced significant improvement of hyperglycemia (p<0.001) both at 60 and 120 min with 
maximum BGL at the 4
th
 h, 46.32%. 
Further, inter group analysis of OGTT revealed there was statistical significance in BGL 
utilization among different doses of extracts in particular AA200 mg/kg/day both with AA100 
mg/kg/day and AA400 mg/kg/day at 120 min (p<0.05, p<0.001) respectively and the same 
analogy was true with the standard. There was also statistical differences AA100 mg/kg/day in 
comparison with AA400 mg/kg/day at 120 min. In the same manner as the above models here 
also AA200 mg/kg/day and GL5 mg/kg/day compete to each other in utilizing glucose. 
Intra-group analysis revealed that there was statistical significance beginning from 60 min 
onwards compared to 30 min for AA100 mg/kg/day, AA200 mg/kg/day and the standard but not 
for the vehicle and the higher dose. 
Table 4: The Effects of 80% methanolic root extract of Asparagus africanus on Oral Glucose 
Tolerance Test in rats 
 
Group 
Blood glucose level in mg/dL 
0min 30min 60min 120min                
Dist H2O 84.45±2.23 134.33±1.89 125.61±1.36 116.11±2.42  
GL5 mg 84.95±2.83 125.22±3.71 81.33±4.69a3e3 67.22±2.51a3b3d3e3  
AA100 mg 85.56±2.49 147.84±6.11 100.11±5.03
a2e1 93.22±1.51a3d2e3  
AA 200 mg 85.72±1.04 140.67±5.84 92.83±2.96
a3e2 78.00±6.90a3b2d3e3  
AA 400 mg 93.17±7.53 155.89±6.74 102.33±9.44
a1e1 109.17±3.78   
Values are mean±SEM. n=6; 
a
compared to Dist H2O;
 b
compared to100 mg; 
c
compared to 200 mg; 
d
compared to 
400mg;
 e
compared to 30min; 
1
p<0.05; 
2
p<0.01; 
3
p<0.001. (Distilled H2O, negative control; GL 5 mg, glibenclamide; 
5 mg/kg; AA100, AA200 & AA400= A.africanus extracts mg /kg/day). 
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5. DISCUSSION 
Currently management of Diabetes Mellitus and its complications with minimal side effect 
agents is the major challenge to the medical care system (47). Hence this leads to extensive 
investigation of efficacious and potent natural antidiabetic products with fewer side effects of 
plant origin. The current study on A. asparagus is among primarily focuses on plants since they 
are source of secondary metabolites which are implicated in amelioration of DM and related 
complications with the hope to come up with less side effects or non toxic antidiabetic agent.  
 Streptozotocin (STZ) is by far the most frequently used diabetogenic agent (69%) in the  
preparation of diabetic animal models for the investigation of multiple aspects of diabetes (38). It 
is DNA alkylating agent which is glucose analogue, cytotoxic to pancreatic β-cells and its effects 
can be seen within seventy two hours after administration depending on the dose administered. 
In fact the dose required for inducing diabetes depends on the animal species, route of 
administration and nutritional status of the animals (48, 49). Partially destructed beta cells by 
STZ resulted in insufficient insulin secretion causing type II diabetes which is very important for 
the advancement of our knowledge and understanding of the various aspects of its pathogenesis 
and ultimately finding new therapies. Thus STZ induced animal model of diabetes is widely 
accepted and reported to resemble that of human hyperglycemic non ketotic diabetes mellitus 
(32, 43). As a result, this model was selected in the present study.  
The acute oral toxicity test of A. africanus extract in mice produced no sign of toxicity or death 
even at the dose of 5000 mg/kg which shows very safe, well tolerated and non toxic in the tested 
rodents which is similar to studies done earlier (27, 28), though direct extrapolation to human is 
difficult due to inter species variation. The test doses are determined based on the acute toxicity 
study of the limit test of 2000 mg/kg which is the lower dose level calculated by taking half of 
the middle dose, that would be 100 mg/kg and the middle dose is one tenth of the limit dose 
which is 200 mg/kg. Higher dose is calculated as twice the middle dose becomes 400 mg/kg (3). 
Even though the extract is non toxic up to 5000 mg/kg the lower limit dose is selected for the test 
doses because most literatures stated that extracts have no as such practical antidiabetic activity 
above 200 mg/kg extract (32, 42, 50, 51), in which this study also goes in line with. 
21 
 
 The assessment of the glucose handling in experimental rodents of A.africanus root extract is 
successfully achieved by determination of secondary metabolites through phytochemical 
screening using standard procedures which are positive for flavonoids, terpenoids, phenols, 
saponins, alkaloids and others (Table1). They are potential bioactive molecules of this plant 
which are responsible for ameliorating chronic hyperglycemia as their potential effects are 
confirmed in normal fasted, STZ induced diabetic mice and glucose utilizing capacity in 
postprandial rats. 
The study has shown that no detectable changes observed in baseline BGL across groups in both 
normal (Table 2) as well as diabetic mice (Table 3), however, significant BGL reductions started 
to appear after the hydroalcoholic extract and the standard drug are administered, indicating that 
changes produced are attributed to treatments received. Therefore, results of this study obviously 
indicates that the extract reduces BGL level in normal, in fact AA200 mg only, and diabetic mice 
for all different doses of extract plus in glucose induced hyperglycemic rats.  
Among the various doses of the extract, maximum activity is achieved with AA200 mg in all test 
models. It is great success this dose is capable of bringing down Streptozocin-induced 
hyperglycemia close to the standard drug values (Table 3). This dose of extract also brought the 
hyperglycemic state in OGTT down within 60 min (p<0.01) and with the same level of 
significance (p<0.001) at 120 min in the same pattern with that of GL5 (Table 4). This oral 
glucose tolerance test also confirmed blood glucose lowering activity of A. africanus extract in 
steady state manner. Thus, it is possible to speculate that the extract and glibenclamide might 
produce hypoglycemic, antidiabetic and enhancing of glucose utilization effects by similar 
mechanisms in diabetes that means by enhancing insulin release or insulin-like effect. Because 
its genus and other numerous plants extract have been reported to have similar mode of action 
with that of glibenclamide, providing evidence to this similar insulin enhancing to utilize glucose 
and insulin releasing effects of the root extract (2, 21). 
 It was observed that the extract exerted its action in a non-dose dependent but time dependant 
manner; because the higher dose produced less activity and maximum activities achieved in all 
models in the last hours except AA400 mg in OGTT model. This could be the active principles 
in the extract need time to reach sufficient concentration at the target site or in the higher doses  
there could be other interfering substances those preclude the expected higher hypoglycemic 
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effect, as a similar pattern was reported with its many species of the genus Asparagus, in fact for 
some with dose dependent actions, and other plants (2, 39, 52, 53).   
 The lower dose, AA100 mg of the extract appeared to be ineffective in reducing BGL in normal 
mice (Table 2). This could be attributed to inability of the dose to overcome counter-regulatory 
physiological mechanisms of the lesser concentration active principles to induce hypoglycemia 
or the small sample size employed that prohibited statistical significance. AA400 mg also failed 
to  lower BGL at all time points in normal mice, this is probably  due to the presence of other 
interfering substances with the active principles at the higher doses (32) or the extract is having 
reducing sugar so the mice  may be utilized it. This observation suggests that activity might 
decrease with dose, because BGL reduction is, most likely, the synergistic effects among various 
constituents of the extract (32, 39).  
On the other hand, AA100 mg produced antidiabetic action in Streptozocin-induced mice, which 
might imply that the hypoglycemic nature of the lower dose would be apparent when there is an 
alteration in normal blood glucose regulatory mechanisms in diabetes. This could be explained 
by; during fasting time the body stimulates the release of the hormone glucagon, which in turn 
releases glucose into the blood through catabolic processes. Normally, the body produces and 
processes insulin to counteract the rise in glucose levels but in diabetes, this process is impaired  
(11), so this blood glucose lowering effect in altered pancreas is most likely as a result of 
antidiabetic activity of the extract via its different mechanisms action achieved in of diabetic 
mice with lower dose, that may relief oxidative stress, regeneration of β-cells which lost as a 
result of cytotoxic effects of STZ. On the other hand, this is why the AA100 mg might be failed 
to induce hypoglycemia in normal mice but in diabetic once. 
Interestingly, in OGTT the extract showed significant reduction in BGL from 60 min on-wards 
except for the higher dose. This suggests that the extract has a potential to enhance glucose 
utilizing capacity via different mechanisms, reflecting a potential advantage of the extract in 
minimizing hyperglycemia which is a prerequisite for diabetes related complications (39, 51). 
But in case of the higher dose  the ability of the extract fall to utilize blood glucose as time goes 
on in OGTT model, this is probably due to high glycaemic index of the extract in which both in 
normoglycemic and OGTT tend to raise in BGL in case of higher dose, as supported by other 
studies (39). 
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The overall hypoglycemic, antidiabetic and glucose utilizing potential of the extract is attributed 
to its bioactive constituents because they attenuate diabetes and diabetic complications through 
different mechanisms of actions (54).  
Numerous mechanisms of plants extract actions are proposed: some hypothesis relates to their 
effects on the activity of pancreatic beta cells (insulin release), by inhibiting effect of insulinase, 
increase insulin sensitivity or the insulin-like activity of the plant extracts, increase in peripheral 
utilization of glucose, increase of synthesis of hepatic glycogen or decrease glycogenolysis, 
inhibition of intestinal glucose absorption, reduction of glycaemic index of carbohydrates and 
others (21).  
A number of experimental and clinical studies have indicated that hyperglycemia may directly or 
indirectly contribute to an increased formation of free radicals which has been implicated in 
diabetic and related complications, consequently to the onset of oxidative stress. Oxidative stress 
is a condition of reduction in antioxidant enzymes like superoxide dismutase (SOD), glutathione 
peroxidase and Catalase levels. Thus reducing this oxidative stress is another main target for 
bioactive plant constituents (3, 55-57); here is more discussion for most of them, which are 
identified in root extract of A.africanus. 
 Flavonoids: are known for their health promoting properties due to their high antioxidant 
capacity and have been described to be excellent free radical scavenging agents. They are the 
most widespread polyphenolic substances with hypoglycemic and antidiabetic properties 
constituting active biological principles of most medicinal plants, in which phytochemical testing 
also proved its presence in the studied plant. They mainly act by inhibiting free radical formation 
and propagation of free radical reactions through hydrogen donation and aromatic hydroxylation. 
They reduce oxidative stress leading to less degradation of GSH (glutathione) or either increases 
the biosynthesis of GSH and also leads to the regeneration of pancreatic β-cells, reduces necrosis 
and degeneration, thus may be effective in treating hyperglycemia thereby preventing  diabetes 
and its complications as found in extract of A.africanus (16, 51).  
Alkaloids: since the extract was positive for alkaloids which are implicated in producing anti 
hyperglycemic action by potentiating pancreatic secretion of insulin from β-cell of islets or by 
enhancing transport of blood glucose to peripheral tissue are able to restore the reduced GSH 
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content in diabetic liver which play an important role in prevention of diabetic complications, in 
addition can modulates enzymes responsible for glucose metabolism, reducing oxidative stress 
and thus helps in restoring antioxidant status (58).  
Phenolic constituents: The scavenging ability of the phenolic is mainly due to the presence of 
hydroxyl groups. Being a potent radical scavenger it inhibits the free radical mediated formation 
of advanced glycation end products and thus are beneficial for counteracting hyperglycemia and 
complications associated with diabetes (49, 54). Moreover, enhanced insulin secretion by 
regeneration of β-cells reduces oxidative stress and modulates enzymes responsible for glucose 
metabolism. (59). Plants rich in phenolic content as A.africanus have been reported to possess 
higher antioxidant activities even than vitamins and synthetic antioxidants, indicating their 
ability to reduce blood glucose concentration and subsequent oxidation (56, 60) so the extract 
most likely does some of these actions. 
Terpenoids: stimulate release of insulin from pancreas and ameliorates oxidative stress, thus can 
be effective in management of diabetes and related complications (59). Saponins and tannins are 
also attributes to observed hypoglycemic effects of A.africanus extract (56). Not only these but 
also other miscellaneous constituents of the plant extract in which we did not test might also 
speculated to attenuate diabetes and its complications by different mechanisms of modulation of 
pancreas or extra pancreatic effects as most are already mentioned. 
  Furthermore, chemical constituents of A.africanus root extract are similar with previously done 
studies on the different species of Asparagus, which is clue for speculation for the same 
mechanism of actions. For instance, the root extract of A. racemosus (2) increased insulin 
secretion in the isolated islets of rats in vitro (61) and A. officinalis treated diabetic rats showed 
antidiabetic effects. The A. officinalis treated diabetic rats again showed improvement in the size 
of the islets of the pancreas (52). Thus the overall anti diabetic effects of the root extract of 
A.africanus is most likely due to the enhanced insulin secretion from the pancreatic β-cells in 
tested rodents in similar fashion as those of its species. The clinical trial done on A. officinalis 
augments the confirmation of similar biological effects in terms of glucose metabolism through 
insulin secretion of the plant extract (62). 
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The major probable mechanisms of the extract that causes insulin secretion are: suppression of 
oxidative stress, increasing viability and proliferation of β-cells, through increasing ATP/ADP 
ratio and intracellular Ca
2+
 concentration and others by combined synergistic actions (47) 
because the plant extract possesses numerous bioactive constituents for the implicated actions. 
Therefore from numerous evidences suggested above the mechanisms of BGL lowering actions 
of hydroalcoholic extract in normal fasted, diabetic mice and glucose loaded rats are most likely 
due to increase in insulin level in plasma by increasing either the pancreatic secretion of insulin 
from existing beta cells or in the long run by regenerating pancreatic beta cells subsequently 
secretion of insulin, its release from the bound form, antioxidant activity or exert its antidiabetic 
actions through extra-pancreatic, most likely by synergism or individually of the detected 
secondary metabolites of root extract in tested rodents.  
Thus this study clearly indicated that the root extract of A.africanus Lam. could be considered as 
a potential candidate for management of diabetes, through different proposed mechanism of 
actions either modulating the pancreas, particularly by insulin releasing or extra-pancreas effects 
supporting the traditional claim. 
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6. CONCLUSION  
Phytochemical screening of A.africanus demonstrated that the root extract constitute the major 
bioactive potential molecules which are implicated in amelioration of diabetes and related 
complications. The root extract has a very wide safety margins in tested mice which was non 
toxic up to the dose of 5000 mg/kg. The plant extract showed antidiabetic activity in all 
employed rodent models, in non-dose dependant but time dependant manner. Therefore, this 
study clearly indicated that the extract could be considered as a potential candidate for the 
management of diabetes.  
 However, further investigation is required for its effects on antioxidant  activity,  isolation and  
characterization  of  the  antidiabetic  bioactive  compound  and the  establishment  of  the  exact  
mechanism(s)  of  action. Thus, this study supports the traditional use of the root of A. africanus 
with a very wide safety margin on studied rodents, even though direct extrapolation to human is 
inconclusive, for the management of diabetes mellitus. 
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7. RECOMMENDATIONS 
Based on the present study the following recommendations are proposed: 
 Conservation of this precious medicinal plant  
  Investigation of its antioxidant and lipid profile  
 Beside the roots, other parts might require investigations of its antidiabetic activity  
 Fractionation, isolation and characterization of antidiabetic bioactive compound and the  
establishment of the exact mechanism(s) of action and  
 Further toxicological studies including chronic toxicity  
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ANNEX  
 
1. Phytochemical Screening Test (Qualitative Method) 
1.Test for alkaloids: Weigh 1g of methanolic dry extract and dissolve 10ml of acid alcohol and 
boiled for 20minutes at 100 °C in a water bath and filter using Whatman filter paper, take 5ml 
of the filtrate, add 2ml 10% ammonia, 5ml chloroform and shake gently to extract the alkaloid 
base. Extract the chloroform layer with 10ml of 70 % acetic acid and divide the solution in two 
portions in a test tube 
A. Few drops of Mayer’s reagent (HgCl3 and KI solution) was added to one portion, creamy 
precipitate was observed indicating the presence of alkaloids  
B. Wagner’s test: Few drops of Wagner’s reagent (Prepared solution of 1.27 gm Iodine and 2 
gm KI in 100 ml distilled water) 2-3 ml added to the test sample; reddish brown color was 
observed confirming the presence of alkaloids. 
2.Test for Flavonoids: Weigh 0.2g of extract and 10ml of ethylacetate was added heated on a 
water bath for 3 minutes. The solution was cooled, filtered then tested for the presence of 
flavonoids. A.  Ammonium test: On 3ml of filtrate 1ml of diluted (10%) ammonium solution 
was added and then shaken. The yellow color  observed in the ammonia layer indicating the 
presence of the flavonoids 
B.  Aluminum chloride solution (1% test): 3ml of the filtered solution was shaken with 1ml of 
1% aluminum chloride solution. The separated yellow color was formed on the aluminum 
chloride confirming indicates the presence of flavonoids.                          
3.Test for saponins: weigh One gram of  extract dry powder and dissolve in 5ml distilled water, 
boiling for 20 minutes at 100 °C in a water bath and filter using Whatman filter paper and add 
3ml distilled water  to the filtrate, shake vigorously for about 5 minutes. Frothing which 
persisted on warming is taken as an evidence for the presence of saponins. 
4.Test for tannins: weigh 0.5g of the extract dry powder and dissolve in 10ml of distilled water 
and boiling for 20 minutes at about 100 °C in a water bath and filter using Whatman filter 
paper and add 3 drops of 0.1% of ferric chloride to the filtered solution. A brownish green or 
blue black coloration indicate the presence of tannins. 
5. Sterols determination: weigh 0.2g of dry extract powder, dissolve in 10ml chloroform and 
shake to ensure dissolution, add 2ml of 70% acetic acid to the solution cool in ice in 
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refrigerator for 15 minutes and add 2ml of concentrated sulfuric acid carefully. The color 
from violet to green in some samples indicates the presence of steroids.  
6. Test for cardiac glycosides: weigh 0.5g of dry powder extract and dissolve in 5ml of distilled 
water, treated with 2 ml of glacial acetic acid, one drop of 0.1% ferric chloride solution added 
and finally added 1ml of concentrated sulfuric acid. A violet ring appear below the brown ring 
or a greenish ring form just above the brown ring and gradually spread throughout this layer 
which confirmed the presence of glycoside.  
7. Test for terpenoids:  weigh 0.2g of dry extract dissolved in 2ml distilled water to form 
10%w/v solution of the extract,  add  2ml of chloroform and shake, then add 3ml concentrated 
sulfuric acid  carefully to form a layer. A reddish brown colouration of the interface formation 
indicates positive results for the presence of terpenoids. 
8. Tests for anthraquinones: weigh 1g of dry powder extract, dissolve in 10 ml of benzene shake, 
filtered with Whatman filter paper, add 5ml of 10% ammonia solution to the filtrate and 
shake. The presence of a pink, red or violet colour in the ammonical (lower) phase indicates 
the presence of free anthraquinones. 
9. Test for reducing sugar: weigh 1g of dry powder extract; dissolve in 10 ml distilled water then 
filtered. Filtrate was treated with Benedict’s reagent (1gm sodium carbonate, 1.73gm sodium 
citrate and 0.173gm copper sulfate solution) heated gently for 5 min. Orange red precipitate 
indicates the presence of reducing sugars. 
10. Test for phenols:-Weigh0.2g of dry powder extract, dissolve in 5ml of 95% ethanol then add 
2 drops of 1M ferric chloride solution. The presence of intense color indicates the presence of 
phenols. 
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2. Preparation buffer solution to adjust Streptozocin (PH =4.5) 
Preparation of 0.1 M citrate buffer (pH 4.5) 
                0.1M citric acid solution. 
5.26 g citric acid monohydrate (MW = 210.14 g/mole) was weighed and in dissolved in 250 ml 
distilled water.  
                 0.1 M tri sodium citrate solution  
In the same manner 7.36 g tri sodium citrate dihydrate (MW = 294.12 g/mole) was weighed 
dissolved in 250 ml distilled water. 
 For the preparation of 100 ml 0.1 M citrate buffer (pH = 4.5), 47 ml 0.1 M citric acid solution 
was mixed with 53 ml 0.1 M  tri sodium citrate solution to give  a  0.1 M citrate buffer solution  
with pH = 4.5.  The solution was kept in refrigerator at 1- 4oC for future use. Then the PH was 
adjusted to 4.5 by adding 0.1M Hcl and 0.1M NaOH drop wise. 
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